HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Livia Lumbroso-Le Rouic Selected Research
Livia Lumbroso-Le Rouic Research Topics
Disease
11
Neoplasms (Cancer)
12/2021 - 07/2006
11
Retinoblastoma (Glioblastoma, Retinal)
12/2021 - 08/2008
8
Melanoma (Melanoma, Malignant)
10/2023 - 07/2007
4
Neoplasm Metastasis (Metastasis)
07/2021 - 07/2006
3
Uveal melanoma
01/2022 - 07/2006
3
Cicatrix (Scar)
01/2021 - 01/2012
2
Neovascular Glaucoma
07/2013 - 01/2012
1
Genetic Predisposition to Disease (Genetic Predisposition)
12/2021
1
Ischemia
01/2021
1
Hypotension (Low Blood Pressure)
01/2021
1
Glaucoma
10/2019
1
Cataract (Cataracts)
10/2019
1
Chromosome Aberrations (Chromosome Abnormalities)
08/2019
1
Hemangioma (Angioma)
04/2019
1
Hemorrhage
04/2018
1
Toxic Optic Neuropathy
02/2014
1
Margins of Excision
04/2013
1
Inflammation (Inflammations)
01/2012
1
Residual Neoplasm
01/2012
1
B-Cell Lymphoma (Lymphoma, B Cell)
09/2010
1
Infections
09/2010
1
Ototoxicity
05/2009
1
Hearing Loss (Hearing Impairment)
05/2009
1
High-Frequency Hearing Loss
05/2009
1
Necrosis
12/2008
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2008
1
Sarcoma (Soft Tissue Sarcoma)
08/2006
1
Retinal Detachment (Retinal Detachments)
07/2006
1
Second Primary Neoplasms (Neoplasms, Second)
06/2006
Drug/Important Bio-Agent (IBA)
8
Protons (Proton)
IBA
08/2019 - 07/2006
3
Retinaldehyde (Retinal)
IBA
01/2021 - 07/2006
2
Biomarkers (Surrogate Marker)
IBA
12/2021 - 07/2021
2
Melphalan (Alkeran)
FDA Link
Generic
01/2021 - 07/2017
2
Carboplatin (JM8)
FDA Link
Generic
05/2009 - 08/2008
1
Fluorescein (Funduscein)
FDA Link
Generic
10/2023
1
Cell-Free Nucleic Acids
IBA
12/2021
1
DNA (Deoxyribonucleic Acid)
IBA
12/2021
1
Drug Combinations
IBA
01/2021
1
Retinoblastoma Protein
IBA
01/2020
1
beta Subunit Luteinizing Hormone
IBA
01/2018
1
Thiotepa (Triethylenethiophosphoramide)
FDA Link
Generic
04/2013
1
Dihydrotachysterol (AT 10)
IBA
01/2012
1
Cytokines
IBA
01/2012
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2012
1
Antigens
IBA
09/2010
1
Iodine
IBA
12/2008
1
Cobalt
IBA
12/2008
1
Rituximab (Mabthera)
FDA Link
08/2008
1
Monoclonal Antibodies
IBA
08/2008
1
Etoposide (VP 16)
FDA Link
Generic
08/2008
Therapy/Procedure
8
Therapeutics
01/2022 - 08/2008
8
Radiotherapy
10/2019 - 06/2006
7
Conservative Treatment
07/2021 - 08/2008
5
Drug Therapy (Chemotherapy)
01/2021 - 06/2006
5
Proton Therapy
10/2019 - 07/2006
3
Aftercare (After-Treatment)
06/2014 - 07/2007
3
Induced Hyperthermia (Thermotherapy)
07/2013 - 08/2008
2
Neoadjuvant Therapy
01/2020 - 08/2008
1
Immunotherapy
01/2022
1
Anesthesia
01/2018
1
Adjuvant Chemotherapy
04/2013
1
Consolidation Chemotherapy
04/2013
1
Brachytherapy
01/2012
1
Intravitreal Injections
01/2012
1
Hearing Aids (Hearing Aid)
05/2009